Literature DB >> 30551200

Association of Upregulated Angiogenic Cytokines With Choroidal Abnormalities in Chronic Central Serous Chorioretinopathy.

Nobuhiro Terao1, Hideki Koizumi2, Kentaro Kojima1, Tetsuya Yamagishi1, Kenji Nagata1, Koji Kitazawa1, Yuji Yamamoto1, Kengo Yoshii3, Asako Hiraga4, Munetoyo Toda4, Shigeru Kinoshita4, Chie Sotozono1, Junji Hamuro1.   

Abstract

Purpose: To clarify the distinct molecular pathogenesis of central serous chorioretinopathy (CSC) and pachychoroid neovasculopathy (PNV).
Methods: Aqueous humor (AH) was collected from 18 acute CSC, 20 chronic CSC, and 20 PNV patients. Concentrations of 30 cytokines in the AH were analyzed using a multiplex bead immunoassay, and the cytokine profiles were compared among these three groups of patients. The areas of choroidal vascular hyperpermeability (CVH) and choroidal thickness (CT), including measurement of the vascular layers, were investigated to analyze the features of choroidal abnormality in acute CSC, chronic CSC, and PNV. Additionally, associations between cytokine profiles and choroidal abnormalities were analyzed.
Results: Proinflammatory cytokines, IL-6 and IL-8 were significantly upregulated in the chronic CSC group compared with the acute CSC or PNV groups. Angiogenic cytokines and VEGF-A were upregulated at levels that almost reached significance along with disease progression from acute to chronic CSC, whereas the upregulation was not significant from chronic CSC to PNV. In the chronic CSC group, strong positive correlations were confirmed between VEGF-A and placental growth factor (PlGF) (r = 0.75, P < 0.001) and IL-6 and VEGF-A (r = 0.74, P < 0.001), and angiogenesis-related cytokines were positively correlated with the typical choroidal abnormalities, areas of CVH, mean CT, and mean large choroidal vessel layer thickness. However, there was no association between these choroidal abnormality parameters and AH cytokines in the PNV group. Conclusions: The results suggest that choroidal abnormalities in chronic CSC may be associated with upregulated angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30551200     DOI: 10.1167/iovs.18-25517

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Authors:  Pushpinder Kanda; Arnav Gupta; Chloe Gottlieb; Rustum Karanjia; Stuart G Coupland; Manpartap Singh Bal
Journal:  Eye (Lond)       Date:  2021-10-15       Impact factor: 4.456

2.  Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents.

Authors:  Benedikt Schworm; Nikolaus Luft; Leonie F Keidel; Felix Hagenau; Christoph Kern; Tina Herold; Karsten U Kortuem; Siegfried G Priglinger; Jakob Siedlecki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-02-28       Impact factor: 3.117

3.  The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya; Lely Retno Wulandari
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

4.  Choroidal congestion mouse model: Could it serve as a pachychoroid model?

Authors:  Hidetaka Matsumoto; Ryo Mukai; Junki Hoshino; Mai Oda; Toshiyuki Matsuzaki; Yasuki Ishizaki; Koji Shibasaki; Hideo Akiyama
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

5.  Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.

Authors:  Yutaka Kato; Yasuharu Oguchi; Tomoko Omori; Hiroaki Shintake; Ryutaro Tomita; Akihito Kasai; Masashi Ogasawara; Yukinori Sugano; Kanako Itagaki; Akira Ojima; Takeshi Machida; Hideharu Sekine; Tetsuju Sekiryu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

6.  Comparison of Intraocular Cytokine Levels of Choroidal Neovascularization Secondary to Different Retinopathies.

Authors:  Chenyi Liu; Shian Zhang; Xinyi Deng; Yijing Chen; Lijun Shen; Liang Hu; Jianbo Mao
Journal:  Front Med (Lausanne)       Date:  2021-12-21

7.  Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy.

Authors:  Michał Chrząszcz; Weronika Pociej-Marciak; Katarzyna Żuber-Łaskawiec; Bożena Romanowska-Dixon; Marek Sanak; Katarzyna Michalska-Małecka; Mojca Globočnik Petrovič; Izabella Karska-Basta
Journal:  Medicina (Kaunas)       Date:  2021-10-05       Impact factor: 2.430

8.  Association between serum soluble fms-like tyrosine kinase-1 and the central choroidal thickness during pregnancy: a prospective study.

Authors:  Takafumi Suzuki; Tatsuya Inoue; Nozomi Igarashi; Chisato Agata; Atsushi Okubo; Takeshi Nagamatsu; Takayuki Iriyama; Maiko Maruyama-Inoue; Yasuo Yanagi; Kazuaki Kadonosono; Ryo Asaoka; Keiko Azuma; Ryo Obata
Journal:  BMJ Open Ophthalmol       Date:  2021-11-05

9.  CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Nobuhiro Terao; Naoya Imanaga; Sorako Wakugawa; Shota Sawaguchi; Tamaki Tamashiro; Yukihide Yamauchi; Hideki Koizumi
Journal:  Retina       Date:  2022-04-01       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.